Bioventus
BVS
98 hedge funds and large institutions have $232M invested in Bioventus in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 23 reducing their positions, and 22 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 23
3.09% more ownership
Funds ownership: 52.32% → 55.41% (+3.1%)
7% less funds holding
Funds holding: 105 → 98 (-7)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
48% less capital invested
Capital invested by funds: $447M → $232M (-$215M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$11.9M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
+$6.32M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$4.56M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2.98M |
| 5 |
BlackRock
New York
|
+$2.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$7.67M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.31M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.24M |
| 4 |
HF
HRT Financial
New York
|
-$1.18M |
| 5 |
DIA
Dean Investment Associates
Beavercreek,
Ohio
|
-$882K |
BVS Hedge Fund Activity: Q2 2022 in Review
98 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q2 2022, worth a combined $232M — down 48% from $447M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of BVS and 18 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 46 added.
The largest buyer was Bank of America, adding an estimated $11.9M. The largest seller was Nuance Investments, cutting an estimated $7.67M.
- 98 institutional investors held Bioventus (BVS) as of Q2 2022, down from 105 in Q1 2022.
- Funds reported $232M of Bioventus stock for Q2 2022, down 48% quarter-over-quarter.
- 18 funds opened new Bioventus positions in Q2 2022 and 22 closed out, a net change of -4 holders.
- The largest Bioventus buyer in Q2 2022 was Bank of America, an estimated $11.9M added.
- The largest Bioventus seller in Q2 2022 was Nuance Investments, an estimated $7.67M sold.
Based on aggregated 13F filings for Q2 2022.